Apteka Exhibition Russian Health Care Week UFI Approved Event
To main
For exhibitors
For visitors
Program
Contacts

Watson buys Uteron Pharma

25.01.2013

Watson Pharmaceuticals Inc. has acquired Belgium-based Uteron Pharma SA for up to $ 305 million — $150 million in cash up-front, and up to $155 million in potential future milestone payments as the drug company aims to expand its pipeline of women’s health products. Watson said the deal brings it two potential near-term global commercial opportunities in contraception and infertility, and one novel oral contraceptive, projected to launch globally in 2018.

Watson Pharmaceuticals Inc. is one of the largest generics pharmaceutical manufacturers in the USA that markets more than 6,000 pharmaceutical products. The company is focused on developing, manufacturing and distributing generic, brand and biosimilar products, principally in urology and women’s health. The product family also includes oral contraceptives, generic version of the opiate narcotic pain medications, as well as BPH drugs, gel for overactive bladder treatment, etc. The company employs 6000 people.

Source: pharmvestnik.ru


Back to the list

exhibitor's opinion
Photo gallary

Invite partners to the exhibition
Facebook Youtube RSS Feed





Contacts Flashback Site map
119002 Moscow, Arbat str., 35, of. 423
Тel: +7 (495) 925-65-61/62
Fax: +7 (499) 248-07-34